cupure logo
doctorweighttoldcancerwarnpeoplekeysymptomsheartcure

Experimental cholesterol pill cuts heart attack risk with 'convenient' once-daily dose

Experimental cholesterol pill cuts heart attack risk with 'convenient' once-daily dose
Clinical trial shows Obicetrapib pill lowers bad cholesterol and lipoprotein(a) in high-risk patients on maximum cholesterol therapy, offering hope for treatment-resistant cases.

Comments

Health news